Mendel Money Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.31M | Buy |
14,571
+2,423
| +20% | +$1.16M | 2.67% | 6 |
|
|
2026
Q1 | $5.97M | Buy |
12,148
+696
| +6% | +$378K | 2.5% | 4 |
|
|
2025
Q4 | $6.64M | Buy |
11,452
+39
| +0.3% | +$22.1K | 2.78% | 4 |
|
|
2025
Q3 | $5.54M | Buy |
11,413
+109
| +1% | +$50.7K | 2.33% | 6 |
|
|
2025
Q2 | $4.58M | Buy |
11,304
+475
| +4% | +$199K | 2.03% | 11 |
|
|
2025
Q1 | $5.39M | Buy |
10,829
+47
| +0.4% | +$25.5K | 2.55% | 5 |
|
|
2024
Q4 | $5.61M | Sell |
10,782
-128
| -1% | -$70.4K | 2.5% | 6 |
|
|
2024
Q3 | $6.75M | Sell |
10,910
-152
| -1% | -$90K | 2.92% | 3 |
|
|
2024
Q2 | $6.12M | Sell |
11,062
-202
| -2% | -$116K | 2.86% | 4 |
|
|
2024
Q1 | $6.55M | Sell |
11,264
-759
| -6% | -$426K | 3.03% | 3 |
|
|
2023
Q4 | $6.38M | Buy |
12,023
+475
| +4% | +$230K | 3.07% | 3 |
|
|
2023
Q3 | $5.85M | Sell |
11,548
-277
| -2% | -$148K | 3.13% | 3 |
|
|
2023
Q2 | $6.17M | Sell |
11,825
-85
| -0.7% | -$45.9K | 3.17% | 2 |
|
|
2023
Q1 | $6.86M | Sell |
11,910
-967
| -8% | -$545K | 3.7% | 2 |
|
|
2022
Q4 | $7.09M | Buy |
12,877
+59
| +0.5% | +$31.3K | 4.03% | 1 |
|
|
2022
Q3 | $6.5M | Buy |
12,818
+13
| +0.1% | +$7.28K | 4.05% | 1 |
|
|
2022
Q2 | $6.96M | Sell |
12,805
-135
| -1% | -$74.3K | 4.15% | 2 |
|
|
2022
Q1 | $7.64M | Buy |
12,940
+6
| +0% | +$3.45K | 3.73% | 2 |
|
|
2021
Q4 | $8.63M | Sell |
12,934
-812
| -6% | -$507K | 4.98% | 2 |
|
|
2021
Q3 | $7.85M | Sell |
13,746
-98
| -0.7% | -$53.8K | 4.92% | 3 |
|
|
2021
Q2 | $6.98M | Sell |
13,844
-437
| -3% | -$206K | 4.39% | 3 |
|
|
2021
Q1 | $6.52M | Sell |
14,281
-1,590
| -10% | -$759K | 4.26% | 3 |
|
|
2020
Q4 | $7.39M | Sell |
15,871
-1,347
| -8% | -$632K | 5.18% | 2 |
|
|
2020
Q3 | $7.6M | Sell |
17,218
-1,081
| -6% | -$447K | 5.95% | 1 |
|
|
2020
Q2 | $6.63M | Buy |
+18,299
| New | +$6.13M | 5.84% | 2 |
|
|
2019
Q4 | $6.4M | Sell |
19,695
-345
| -2% | -$105K | 5.54% | 2 |
|
|
2019
Q3 | $5.84M | Sell |
20,040
-825
| -4% | -$236K | 5.4% | 2 |
|
|
2019
Q2 | $6.13M | Buy |
+20,865
| New | +$5.75M | 5.86% | 1 |
|
|
2018
Q3 | $6M | Buy |
+24,573
| New | +$5.65M | 5.82% | 2 |
|
|
2017
Q4 | $5.1M | Buy |
+26,872
| New | +$5.15M | 4.9% | 3 |
|
|
2015
Q2 | $5.53M | Buy |
42,615
+330
| +0.8% | +$43K | 5.15% | 1 |
|
|
2015
Q1 | $5.68M | Buy |
42,285
+255
| +0.6% | +$32.9K | 5.28% | 1 |
|
|
2014
Q4 | $5.27M | Sell |
42,030
-360
| -0.8% | -$43.8K | 4.95% | 1 |
|
|
2014
Q3 | $5.16M | Buy |
+42,390
| New | +$5.15M | 5.05% | 1 |
|
Other funds holding TMO
Mendel Money Management's TMO Position: Q2 2026 in Review
Mendel Money Management increased its Thermo Fisher Scientific (TMO) stake by 20% in Q2 2026, buying an estimated $1.16M and bringing the position to 14,571 shares worth $7.31M. The position accounts for 2.67% of the portfolio, ranked #6.
Mendel Money Management first reported a position in TMO in Q3 2014 and has held it in 34 quarters since. The position peaked at $8.63M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mendel Money Management held 14,571 shares of Thermo Fisher Scientific worth $7.31M as of Q2 2026.
- Mendel Money Management bought 2,423 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.16M.
- Thermo Fisher Scientific made up 2.67% of Mendel Money Management's portfolio in Q2 2026, its #6 holding.
- Mendel Money Management first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 34 quarters since.
- Mendel Money Management's Thermo Fisher Scientific position peaked at $8.63M in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mendel Money Management's 13F filing for Q2 2026, filed 30 Jul 2026.